Association for Accessible Medicines v. Frosh
Fourth Circuit holds that Maryland law regulating pharmaceutical drug prices violates the dormant Commerce Clause
Gustavsen v. Alcon Laboratories, Inc.
U.S. Chamber urges First Circuit to reject eye drop class action on Article III standing and preemption grounds
Rafferty v. Merck & Co., Inc.
Massachusetts high court adopts innovator liability theory, imposing tort liability on brand-name drug manufacturers for injuries caused by generics
CNH Industrial N.V. v. Reese
Supreme Court summarily reverses Sixth Circuit decision that adopted presumption in favor of imposing lifetime health benefits under collective bargaining agreements
Gilead Sciences, Inc. v. U.S. ex rel. Campie
U.S. Chamber files amicus brief in support of cert. petition to resolve circuit split on materiality under False Claims Act
Dolin v. GlaxoSmithKline LLC
U.S. Chamber argues that Illinois law does not recognize “innovator liability” theory for manufacturers of FDA approved medication
Zino v. Whirlpool Corp.
U.S. Chamber files amicus brief urging Sixth Circuit to restore clarity and uniformity to the interpretation of retiree health-benefit plans
Kindred Hospitals East LLC v. Klemish
Supreme Court declines to summarily reverse Florida rule restricting arbitration of medical malpractice claims
T.H. v. Novartis Pharmaceuticals Corporation
California Supreme Court accepts “innovator liability” theory, imposing tort liability on brand-name drug manufacturers for injuries caused by generics
McNair v. Johnson & Johnson
U.S. Chamber urges West Virginia Supreme Court of Appeals to reject “innovator liability” theory for manufacturers of FDA approved medication